InvestorsHub Logo
Followers 16
Posts 296
Boards Moderated 0
Alias Born 10/20/2009

Re: havendale post# 91958

Thursday, 02/19/2015 1:42:30 PM

Thursday, February 19, 2015 1:42:30 PM

Post# of 403103
I just sent Dr. Schaffner this email:

Dear Dr. Schaffner,
I just saw your CNBC interview and was disappointed that you seem to be unaware of the new antibiotic, BRILACIDIN, which has just successfully completed a phase 2 trial treating skin infections. Cellceutix Corperation will presenting to the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) to be held in Copenhagen, Denmark from April 25-28, 2015.
Read about CTIX here: http://www.cellceutix.com/
Thank you for your attention,
George Harvey ( a happy shareholder of CTIX)
gh
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News